Study Outlines Barriers to and Facilitators of Flu Vaccine Decisions
According to the 2013 National HealthInterview Survey, the most recent report used by the Centers for Disease Control and Prevention (CDC), only 29.6 percent of adults ages 18 to 48 receive the flu vaccine, and that number increases to 46.5 percent for adults ages 50 to 64and 67.9 percent for adults over 68.
Education and Storytelling: An Antidote to Parental Fears About Vaccine Safety
In the debate between personal freedom and government mandates, healthcare professionals are a reliable resource for vaccine information.
Scientists Develop Needle-Free Measles Vaccine
Scientists at Georgia Institute ofTechnology have developed a needle-free vaccine against measles.
HPV Vaccine: A Dose of Untapped Potential
With an estimated 79 million Americans currently infected with HPV and an additional 14 million infections occurring each year, why are U.S. vaccination rates stagnantly low?
GSK Ebola Shot Is Safe and Provokes an Immune Response
Results from a human trial of GlaxoSmithKline’s Ebola vaccine show it is safe and generates an immune response.
Pediatrics Academy Updates Measles Recommendations
In response to the national measles outbreak, the American Academy of Pediatrics has released updated measles guidelines on its website.
Study Shows No Link Between Autism and Measles Vaccine
A recent study found no link between the measles vaccine and autism.
Mandatory Childhood Vaccines: The Debate
Recent events have re-energized the ongoing debate about mandatory vaccines for children in the U.S. It remains to be seen which side of the controversy will prevail.
Measles Makes a Comeback
The measles resurgence is introducing a whole new generation of physicians to a once-eradicated
and potentially deadly disease.
Shingles Vaccine Developed That Is 97 Percent Effective
GlaxoSmithKline has developed a new shingles vaccine that is 97 percent effective in adults ages 50 years to 70 years.